| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |